Medexprim is very proud to start its new collaboration in the H2020 EU CHAIMELEON project. CHAIMELEON aims to set up a structured repository for health imaging data to be openly reused in AI experimentation for cancer management. By 2024, an… Read More
In this webinar Medexprim and Graticule convened a panel of experts that bridge across geographies and backgrounds to discuss solutions for sharing advanced Real World Data for COVID-19 research. The panel shares their expertise on data needs, data sharing, and… Read More
Romain Cazavan from Medexprim explains the nature of our partnership with Sophia Genetics and how we contribute to providing cleaned data to advance discoveries to fight cancer.
Boston, Mass – US-based Graticule and France based Medexprim announced a partnership today to provide a federated global network to power complex RWE (Real World Evidence) studies. The two companies have established complementary infrastructure and relationships with health systems and… Read More
Overland Park, KS – US-based Softek Illuminate and the entrepreneurial French firm Medexprim announced today they will be combining, distributing and supporting each other’s product offerings as a unified solution for hospital researchers interested in exploiting previously unstructured clinical and… Read More
Sword Group and Medexprim are partnering in view to offer cancer centers and large hospitals a unified solution to facilitate translational research, combining clinical and imaging data.